Dr. Dean Moscovic, DO
Pediatrics (Pediatrics Physician)
- Medicare participating
At a glance
- Medical school
- Michigan State University College of Osteopathic Medicine (1999)
- Years since graduation
- 27
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 554
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1999Medical school: Michigan State University College of Osteopathic Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pediatrics Physician primary
MI license 5101014251 -
Internal Medicine Physician
MI license DM014251
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Beaumont Hospital Royal Oak Royal Oak, MI
- Beaumont Hospital, Troy Troy, MI
- Trinity Health Oakland Hospital Pontiac, MI
- Mclaren Oakland Pontiac, MI
- Mclaren Lapeer Region Lapeer, MI
Medical groups
- Michigan Healthcare Professionals PC (529 clinicians)
- Mclaren Community Based Primary Care Group (56 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 554
- Services billed
- 4,441
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 668 | 404 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 444 | 62 |
| Established patient office or other outpatient visit, 20-29 minutes | 372 | 196 |
| Injection, dexamethasone sodium phosphate, 1 mg | 290 | 33 |
| Annual alcohol misuse screening, 5 to 15 minutes | 221 | 221 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 207 | 207 |
| Annual depression screening, 5 to 15 minutes | 191 | 191 |
| Insertion of needle into vein for collection of blood sample | 150 | 126 |
| Injection of drug or substance under skin or into muscle | 94 | 59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 70 | 67 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 79 payments worth $1,074 in total to this clinician.
| Pfizer Inc. | $253 |
|---|---|
| AbbVie Inc. | $228 |
| Novo Nordisk Inc | $195 |
| AstraZeneca Pharmaceuticals LP | $143 |
| Lilly USA, LLC | $125 |
| Amgen Inc. | $32.61 |
| Hologic Sales and Service, LLC | $28.23 |
| Axsome Therapeutics, Inc. | $23.56 |
| Food and Beverage | $1,074 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $135,356 in research payments for these studies, mostly to the institutions running them.
- A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of Age
Seqirus USA Inc · Completed · NCT06087640 - Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Sanofi US Services Inc. · Active, not recruiting · NCT06676319 - A randomized, double-blind, placebo-controlled, parallel-group, multic
GlaxoSmithKline, LLC. - Lot-to-lot Consistency Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From 2 Months of Age
Sanofi Pasteur Inc. · Recruiting · NCT07348692
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.